Literature DB >> 368285

The role of subregions of the rat major histocompatibility complex in the rejection and passive enhancement of renal allografts.

G G Gallico, G W Butcher, J C Howard.   

Abstract

The laboratory recombinant haplotype H-1acl of the Norway rat has been used in studies of the rejection and passive enhancement of kidney allografts. While the full H-1a haplotype provoked acute rejection, neither of the isolated subregions, H-1Aa and H-1Ba, did so. It was also found that alloantisera raised against either the H-1Aa or the H-1Ba antigens would enhance the grafts. It is suggested that both MHC subregions contain a histocompatibility locus (i) for kidney (as they do for skin) and that in the genetic combinations studied only incompatibility for both provokes a response sufficient for rejection. In other combinations, however, single region incompatibilities may be sufficient.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 368285      PMCID: PMC2184738          DOI: 10.1084/jem.149.1.244

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  16 in total

Review 1.  Passive enhancement and antigens of different regions of the mouse H-2 complex.

Authors:  N A Staines; K Guy; F Fish; J L Sworn; D A Davies; H Festenstein
Journal:  Transplant Proc       Date:  1977-03       Impact factor: 1.066

2.  Antigen-reactive cell opsonization in passive enhancement of rat renal allografts.

Authors:  I V Hutchinson; H Zola
Journal:  Transplant Proc       Date:  1977-03       Impact factor: 1.066

3.  Passive enhancement of rat renal allografts by antibodies to a non-SD (Ag-B) locus analogous to Ia and demonstration of linkage to the MHC.

Authors:  G R Catto; C B Carpenter; T B Strom; R M Williams
Journal:  Transplant Proc       Date:  1977-03       Impact factor: 1.066

4.  Enhancement of heart allograft survival across H-2 complex.

Authors:  W C Davis
Journal:  Transplant Proc       Date:  1977-03       Impact factor: 1.066

5.  What abrogates heart transplant rejection in immunological enhancement?

Authors:  D A Davies; B J Alkins
Journal:  Nature       Date:  1974-02-01       Impact factor: 49.962

6.  Kidney transplants between mice of graded immunogenetic diversity.

Authors:  M Skoskiewicz; C Chase; H J Winn; P S Russell
Journal:  Transplant Proc       Date:  1973-03       Impact factor: 1.066

7.  Antibodies to major histocompatibility antigens produced by hybrid cell lines.

Authors:  G Galfre; S C Howe; C Milstein; G W Butcher; J C Howard
Journal:  Nature       Date:  1977-04-07       Impact factor: 49.962

8.  A recombinant in the major histocompatibility complex of the rat.

Authors:  G W Butcher; J C Howard
Journal:  Nature       Date:  1977-03-24       Impact factor: 49.962

9.  Ia versus K/D antigens in immunological enhancement of tumor allografts.

Authors:  H T Duc; R G Kinsky; G A Voisin
Journal:  Transplantation       Date:  1978-04       Impact factor: 4.939

10.  The differential destructive and enhancing effects of anti-H-2K, H-2D, and anti-Ia antisera on murine skin allografts.

Authors:  I F McKenzie; M M Henning
Journal:  J Exp Med       Date:  1978-02-01       Impact factor: 14.307

View more
  3 in total

Review 1.  The immunology of experimental liver transplantation in the rat.

Authors:  N Kamada
Journal:  Immunology       Date:  1985-07       Impact factor: 7.397

Review 2.  Whither monoclonal antibodies?

Authors:  N A Staines; A M Lew
Journal:  Immunology       Date:  1980-07       Impact factor: 7.397

3.  Immune response genes controlling responsiveness to major transplantation antigens. Specific major histocompatibility complex-linked defect for antibody responses to class I alloantigens.

Authors:  G W Butcher; J R Corvalán; D R Licence; J C Howard
Journal:  J Exp Med       Date:  1982-01-01       Impact factor: 14.307

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.